Y. Ogawa et al., CYTOTOXICITY OF FAS LIGAND AGAINST LYMPHOMA-CELLS WITH RADIATION-INDUCED FAS ANTIGEN, INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2(4), 1998, pp. 435-436
Fas antigen, also termed APO-1 or CD95, is a transmembrane protein and
a member of the tumor necrosis factor receptor/nerve growth factor re
ceptor superfamily which mediates apoptosis upon oligomerization. The
Fas/Fas ligand system is considered to be a key regulator of apoptosis
. Recently, we have demonstrated that Fas antigen expression is induce
d by low-dose irradiation of some types of lymphomas, and we also demo
nstrated that irradiation-induced Fas antigen expression increased wit
h the passage of time until peaking at 48 h after irradiation in CML-C
1, CML-C2, DL-40, and DL-95 cell lines. In this study, we also examine
d the potential cytotoxicity of Fas ligand peptide against several typ
es of lymphoma/leukemia cell lines that showed induction of Fas antige
n expression under irradiation. Flow cytometry analysis was performed
at 6, 24 and 48 h after irradiation. Samples (1x10(6) cells/ml) from i
rradiated and non-irradiated cells of each cell line were incubated wi
th or without 5 mu g/ml of Fas ligand peptide for 2 h at 37 degrees C
in a humidified atmosphere of 5% carbon dioxide (CO2) in air. The kill
ing effect of Fas ligand against cell lines of CML-C1, DL-40, and DL-9
5 were clearly identified as the percentage of cells with Fas antigen
expression induced by irradiation. Concerning HD-70 cell line, for whi
ch soluble Fas antigen has been identified, the killing effects were c
learly observed in samples pre-treated with PBS washings. To our knowl
edge, this is the first report describing a possible application of th
e Fas/Fas ligand system in treatment of certain types of malignancies
in which Fas antigen is inducible by irradiation.